Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance

Antimicrobial peptides (AMPs) are natural antibiotics produced by various organisms such as mammals, arthropods, plants, and bacteria. In addition to antimicrobial activity, AMPs can induce chemokine production, accelerate angiogenesis, and wound healing and modulate apoptosis in multicellular organisms. Originally, their antimicrobial mechanism of action was thought to consist solely of an increase in pathogen cell membrane permeability, but it has already been shown that several AMPs do not modulate membrane permeability in the minimal lethal concentration. Instead, they exert their effects by inhibiting processes such as protein and cell wall synthesis, as well as enzyme activity, among others. Although resistance to these molecules is uncommon several pathogens developed different strategies to overcome AMPs killing such as surface modification, expression of efflux pumps, and secretion of proteases among others. This review describes the various mechanisms of action of AMPs and how pathogens evolve resistance to them.

[1]  Y. Shai,et al.  D-Alanylation of Lipoteichoic Acids Confers Resistance to Cationic Peptides in Group B Streptococcus by Increasing the Cell Wall Density , 2012, PLoS pathogens.

[2]  R. Hancock,et al.  Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. , 2006, Biochimica et biophysica acta.

[3]  A. Schmidtchen,et al.  SIC, a Secreted Protein of Streptococcus pyogenesThat Inactivates Antibacterial Peptides* , 2003, The Journal of Biological Chemistry.

[4]  M. Skurnik,et al.  Temperature‐regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia , 2000, Molecular microbiology.

[5]  K. Lohner.  New strategies for novel antibiotics: peptides targeting bacterial cell membranes. , 2009, General physiology and biophysics.

[6]  A. Schmidtchen,et al.  Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37 , 2002, Molecular microbiology.

[7]  K. Poole.  Efflux pumps as antimicrobial resistance mechanisms , 2007, Annals of medicine.

[8]  R. Gennaro,et al.  Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins , 1990, Infection and immunity.

[9]  Samuel I. Miller,et al.  Differentiation and Distribution of Colistin- and Sodium Dodecyl Sulfate-Tolerant Cells in Pseudomonas aeruginosa Biofilms , 2006, Journal of bacteriology.

[10]  M. Kallassy,et al.  The dlt Operon of Bacillus cereus Is Required for Resistance to Cationic Antimicrobial Peptides and for Virulence in Insects , 2009, Journal of bacteriology.

[11]  L. Yang,et al.  Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.

[12]  G. Seibert,et al.  Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity. , 1992, The Journal of antibiotics.

[13]  Michael R. Yeaman,et al.  Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.

[14]  Sheng-He Huang,et al.  Escherichia coli outer membrane protease OmpT confers resistance to urinary cationic peptides , 2010, Microbiology and immunology.

[15]  V. Nizet,et al.  A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  R. Gennaro,et al.  Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39. , 2001, The Journal of investigative dermatology.

[17]  A. Goldberg,et al.  Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. , 2000, The Journal of clinical investigation.

[18]  F. van Leuven,et al.  Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae , 1995, FEBS letters.

[19]  H. Kalbacher,et al.  Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. , 2009, International journal of antimicrobial agents.

[20]  B. Tharakan,et al.  Current concepts in apoptosis: The physiological suicide program revisited , 2006, Cellular & Molecular Biology Letters.

[21]  A. Goldberg,et al.  Inhibition of ubiquitin-proteasome pathway–mediated IκBα degradation by a naturally occurring antibacterial peptide , 2000 .

[22]  E. Fleming,et al.  Effect of proline position on the antimicrobial mechanism of buforin II , 2011, Peptides.

[23]  H. Sahl,et al.  The co-evolution of host cationic antimicrobial peptides and microbial resistance , 2006, Nature Reviews Microbiology.

[24]  Celine Chan,et al.  Helix Induction in Antimicrobial Peptides by Alginate in Biofilms* , 2004, Journal of Biological Chemistry.

[25]  Samuel I. Miller,et al.  PmrAB, a Two-Component Regulatory System of Pseudomonas aeruginosa That Modulates Resistance to Cationic Antimicrobial Peptides and Addition of Aminoarabinose to Lipid A , 2004, Journal of bacteriology.

[26]  S. Rebuffat.  Microcins in action: amazing defence strategies of Enterobacteria. , 2012, Biochemical Society transactions.

[27]  G. Georgiou,et al.  Identification of OmpT as the Protease That Hydrolyzes the Antimicrobial Peptide Protamine before It Enters Growing Cells ofEscherichia coli , 1998, Journal of bacteriology.

[28]  Chong Li,et al.  Functional interaction of human neutrophil peptide‐1 with the cell wall precursor lipid II , 2010, FEBS letters.

[29]  R. Armstrong,et al.  Cell-specific Induction of Apoptosis by Microinjection of Cytochrome c , 1997, The Journal of Biological Chemistry.

[30]  H. Sahl,et al.  Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors. , 2012, Microbial drug resistance.

[31]  J. Brodbelt,et al.  Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in Gram-positive and Gram-negative bacteria , 2012, Proceedings of the National Academy of Sciences.

[32]  B. Christensson,et al.  Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator , 2001, Nature Medicine.

[33]  Y. Chuang,et al.  A K+ Uptake Protein, TrkA, Is Required for Serum, Protamine, and Polymyxin B Resistance in Vibrio vulnificus , 2004, Infection and Immunity.

[34]  M.D. Carlisle,et al.  Degradation of human alpha- and beta-defensins by culture supernatants of Porphyromonas gingivalis , 2010 .

[35]  Y. Shai,et al.  Mode of action of linear amphipathic alpha-helical antimicrobial peptides. , 1998, Biopolymers.

[36]  Tetsuya Hayashi,et al.  Escherichia coli , 1983, CABI Compendium.

[37]  T. Zendo,et al.  Antimicrobial mechanism of lantibiotics. , 2012, Biochemical Society transactions.

[38]  S. Molin,et al.  Biofilm Induced Tolerance towards Antimicrobial Peptides , 2008, PloS one.

[39]  L. Piddock.  Multidrug-resistance efflux pumps ? not just for resistance , 2006, Nature Reviews Microbiology.

[40]  R. Hancock,et al.  The role of cationic antimicrobial peptides in innate host defences. , 2000, Trends in microbiology.

[41]  L. Cruz-Chamorro,et al.  In vitro biological activities of magainin alone or in combination with nisin , 2006, Peptides.

[42]  E. Groisman,et al.  A Salmonella protein that is required for resistance to antimicrobial peptides and transport of potassium. , 1994, The EMBO journal.

[43]  R. Gallo,et al.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. , 2009, Trends in immunology.

[44]  J. Whittimore,et al.  The Lipid A 1-Phosphatase of Helicobacter pylori Is Required for Resistance to the Antimicrobial Peptide Polymyxin , 2006, Journal of bacteriology.

[45]  D. Moranta,et al.  Klebsiella pneumoniae Capsule Polysaccharide Impedes the Expression of β-Defensins by Airway Epithelial Cells , 2009, Infection and Immunity.

[46]  J. Thomassin,et al.  Role of uropathogenic Escherichia coli OmpT in the resistance against human cathelicidin LL-37. , 2013, FEMS microbiology letters.

[47]  S. Minnich,et al.  Yersinia pestis Two-Component Gene Regulatory Systems Promote Survival in Human Neutrophils , 2009, Infection and Immunity.

[48]  B. de Kruijff,et al.  The lantibiotic nisin, a special case or not? , 1999, Biochimica et biophysica acta.

[49]  H. Sahl,et al.  Lipid II-Based Antimicrobial Activity of the Lantibiotic Plantaricin C , 2006, Applied and Environmental Microbiology.

[50]  C. B. Park,et al.  Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.

[51]  R. Hancock,et al.  Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria , 2000, Antimicrobial Agents and Chemotherapy.

[52]  Samuel I. Miller,et al.  Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides , 1998, Cell.

[53]  K. Brogden.  Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.

[54]  Lori A. S. Snyder,et al.  A Gonococcal Efflux Pump System Enhances Bacterial Survival in a Female Mouse Model of Genital Tract Infection , 2003, Infection and Immunity.

[55]  J. Weitzman.  Extracellular DNA , 2002, Genome Biology.

[56]  N. Thornberry,et al.  Caspases: killer proteases. , 1997, Trends in biochemical sciences.

[57]  V. Nizet,et al.  Streptococcal Inhibitor of Complement Promotes Innate Immune Resistance Phenotypes of Invasive M1T1 Group A Streptococcus , 2010, Journal of Innate Immunity.

[58]  A. Norrby-Teglund,et al.  Cathelicidin LL-37 in Severe Streptococcus pyogenes Soft Tissue Infections in Humans , 2008, Infection and Immunity.

[59]  K. Lohner,et al.  Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems. , 1999, Biochimica et biophysica acta.

[60]  M. Blaser,et al.  Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials , 2011, Virulence.

[61]  P. Lachmann,et al.  The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins , 2004, Immunology.

[62]  James M. Wilson,et al.  Cathelicidins - a family of multifunctional antimicrobial peptides , 2003, Cellular and Molecular Life Sciences CMLS.

[63]  H. Kristensen,et al.  Therapeutic potential of antifungal plant and insect defensins. , 2007, Drug discovery today.

[64]  W. Vollmer,et al.  A Functional dlt Operon, Encoding Proteins Required for Incorporation of d-Alanine in Teichoic Acids in Gram-Positive Bacteria, Confers Resistance to Cationic Antimicrobial Peptides in Streptococcus pneumoniae , 2006, Journal of bacteriology.

[65]  S. Opella,et al.  Structure and orientation of the antibiotic peptide magainin in membranes by solid‐state nuclear magnetic resonance spectroscopy , 1993, Protein science : a publication of the Protein Society.

[66]  Luciana Dini,et al.  Cell death: apoptosis versus necrosis (review). , 2002, International journal of oncology.

[67]  Douglas M. Warner,et al.  Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC‐MtrD‐MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness , 2008, Molecular microbiology.

[68]  R. Titball,et al.  Proteolytic Degradation of Human Antimicrobial Peptide LL-37 by Bacillus anthracis May Contribute to Virulence , 2006, Antimicrobial Agents and Chemotherapy.

[69]  D. Phoenix,et al.  Anionic antimicrobial peptides from eukaryotic organisms. , 2009, Current protein & peptide science.

[70]  B. de Kruijff,et al.  Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[71]  Ju Hyun Cho,et al.  Buforins: histone H2A-derived antimicrobial peptides from toad stomach. , 2009, Biochimica et biophysica acta.

[72]  R. S. Flannagan,et al.  A two-tier model of polymyxin B resistance in Burkholderia cenocepacia. , 2011, Environmental microbiology reports.

[73]  Ø. Samuelsen,et al.  Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B. , 2002, The Journal of antimicrobial chemotherapy.

[74]  P. François,et al.  Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance , 2009, BMC Genomics.

[75]  Samuel I. Miller,et al.  A PhoP-Regulated Outer Membrane Protease of Salmonella enterica Serovar Typhimurium Promotes Resistance to Alpha-Helical Antimicrobial Peptides , 2000, Journal of bacteriology.

[76]  D. Harter,et al.  Current concepts of apoptosis. , 1997, Neurosurgical focus.

[77]  P. Sansonetti,et al.  Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression , 2008, The Journal of experimental medicine.

[78]  ISOLATION AND CHARACTERISATION , 2015 .

[79]  K. Beis,et al.  The role of bacterial membrane proteins in the internalization of microcin MccJ25 and MccB17. , 2012, Biochemical Society transactions.

[80]  J. Wehland,et al.  The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes , 2006, Molecular microbiology.

[81]  M. Dathe,et al.  Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. , 1999, Biochimica et biophysica acta.

[82]  Haifeng Zhang,et al.  Efflux of potassium ion is an important reason of HL-60 cells apoptosis induced by tachyplesin , 2006, Acta Pharmacologica Sinica.

[83]  M. Valvano,et al.  Burkholderia cenocepacia requires RpoE for growth under stress conditions and delay of phagolysosomal fusion in macrophages. , 2008, Microbiology.

[84]  M. Zanetti.  Cathelicidins, multifunctional peptides of the innate immunity , 2004, Journal of leukocyte biology.

[85]  Joanna B. Goldberg,et al.  The multifarious, multireplicon Burkholderia cepacia complex , 2005, Nature Reviews Microbiology.

[86]  Michelle D. Brazas,et al.  Contribution of the PhoP-PhoQ and PmrA-PmrB Two-Component Regulatory Systems to Mg2+-Induced Gene Regulation in Pseudomonas aeruginosa , 2006, Journal of bacteriology.

[87]  R. Gallo,et al.  Antimicrobial peptides: Old Molecules with New Ideas , 2011, The Journal of investigative dermatology.

[88]  W. Kamysz,et al.  Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock , 2002, Antimicrobial Agents and Chemotherapy.

[89]  L. Martínez-Martínez,et al.  Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence , 2009, Antimicrobial Agents and Chemotherapy.

[90]  H. Sahl,et al.  Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase , 1987, Journal of bacteriology.

[91]  W. Shafer,et al.  Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis , 2005, Journal of bacteriology.

[92]  C. Subbalakshmi,et al.  Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.

[93]  Alginate as an auxiliary bacterial membrane: binding of membrane-active peptides by polysaccharides. , 2005, The journal of peptide research : official journal of the American Peptide Society.

[94]  V. Nizet,et al.  d-Alanylation of Teichoic Acids Promotes Group A Streptococcus Antimicrobial Peptide Resistance, Neutrophil Survival, and Epithelial Cell Invasion , 2005, Journal of bacteriology.

[95]  H. Kalbacher,et al.  Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides* , 1999, The Journal of Biological Chemistry.

[96]  R. Hancock,et al.  Cathelicidins and functional analogues as antisepsis molecules , 2007, Expert opinion on therapeutic targets.

[97]  R. Hancock,et al.  Cationic antimicrobial peptides activate a two‐component regulatory system, PmrA‐PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa , 2003, Molecular microbiology.

[98]  R. P. Ross,et al.  Two-peptide lantibiotics: a medical perspective. , 2007, Mini reviews in medicinal chemistry.

[99]  H. Vogel,et al.  Mechanism of action of puroindoline derived tryptophan-rich antimicrobial peptides. , 2013, Biochimica et biophysica acta.

[100]  K. Mukhopadhyay,et al.  Differential Adaptive Responses of Staphylococcus aureus to In Vitro Selection with Different Antimicrobial Peptides , 2013, Antimicrobial Agents and Chemotherapy.

[101]  A. Cox,et al.  Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance , 1991, Molecular microbiology.

[102]  Francis C. Neuhaus,et al.  A Continuum of Anionic Charge: Structures and Functions of d-Alanyl-Teichoic Acids in Gram-Positive Bacteria , 2003, Microbiology and Molecular Biology Reviews.

[103]  H. G. Boman,et al.  Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine , 1993, Infection and immunity.

[104]  A. Sonenshein,et al.  The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile. , 2011, Microbiology.

[105]  V. Nizet,et al.  M1 Protein Allows Group A Streptococcal Survival in Phagocyte Extracellular Traps through Cathelicidin Inhibition , 2009, Journal of Innate Immunity.

[106]  V. N. Bezmelnitsin,et al.  Isolation and characterisation of C70O , 1997 .

[107]  M. Castanho,et al.  The Mechanism of Action of Antimicrobial Peptides: Lipid Vesicles vs. Bacteria , 2012, Front. Immun..

[108]  Y. Shai,et al.  Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification. , 2009, Biochimica et biophysica acta.

[109]  F. Madeo,et al.  The Antifungal Plant Defensin HsAFP1 from Heuchera sanguinea Induces Apoptosis in Candida albicans , 2011, Front. Microbio..

[110]  Chantal Couture,et al.  Mechanisms of action , 1994, Schizophrenia Research.

[111]  K. Makarova,et al.  Structural and functional characterization of microcin C resistance peptidase MccF from Bacillus anthracis. , 2012, Journal of molecular biology.

[112]  K. Brogden,et al.  Degradation of Human α- and β-Defensins by Culture Supernatants of Porphyromonas gingivalis Strain 381 , 2008, Journal of Innate Immunity.

[113]  Lei Zhu,et al.  An outer membrane protease of the omptin family prevents activation of the Citrobacter rodentium PhoPQ two‐component system by antimicrobial peptides , 2009, Molecular microbiology.

[114]  H. Sahl,et al.  Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. , 2004, The Journal of antimicrobial chemotherapy.

[115]  K. Severinov,et al.  Microcin C: biosynthesis and mechanisms of bacterial resistance. , 2012, Future Microbiology.

[116]  M. Simons,et al.  Molecular basis for proline- and arginine-rich peptide inhibition of proteasome. , 2008, Journal of molecular biology.

[117]  Katsumi Matsuzaki,et al.  Control of cell selectivity of antimicrobial peptides. , 2009, Biochimica et biophysica acta.

[118]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[119]  D. Steinberg,et al.  Resistance of Porphyromonas gingivalis ATCC 33277 to Direct Killing by Antimicrobial Peptides Is Protease Independent , 2007, Antimicrobial Agents and Chemotherapy.

[120]  A. Bayer,et al.  Plasmid-Mediated Resistance to Thrombin-Induced Platelet Microbicidal Protein in Staphylococci: Role of theqacA Locus , 1999, Antimicrobial Agents and Chemotherapy.

[121]  L. Otvos,et al.  Enlarged scale chemical synthesis and range of activity of drosocin, an O-glycosylated antibacterial peptide of Drosophila. , 1996, European journal of biochemistry.

[122]  I. del Castillo,et al.  Construction and Characterization of Mutations at Codon 751 of the Escherichia coli gyrB Gene That Confer Resistance to the Antimicrobial Peptide Microcin B17 and Alter the Activity of DNA Gyrase , 2001, Journal of bacteriology.

[123]  T. Goldmann,et al.  Multiple Peptide Resistance Factor (MprF)-mediated Resistance of Staphylococcus aureus against Antimicrobial Peptides Coincides with a Modulated Peptide Interaction with Artificial Membranes Comprising Lysyl-Phosphatidylglycerol* , 2011, The Journal of Biological Chemistry.

[124]  W. Shafer,et al.  Human Antimicrobial Peptide LL-37 Induces MefE/Mel-Mediated Macrolide Resistance in Streptococcus pneumoniae , 2010, Antimicrobial Agents and Chemotherapy.

[125]  M. Phansalkar,et al.  Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. , 1992, The Journal of antibiotics.

[126]  Marilyn A. Anderson,et al.  Cellular and Molecular Life Sciences Properties and Mechanisms of Action of Naturally Occurring Antifungal Peptides , 2022 .

[127]  H Lecar,et al.  Electrically gated ionic channels in lipid bilayers , 1977, Quarterly Reviews of Biophysics.

[128]  M. Surette,et al.  Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium , 2013, BMC Microbiology.

[129]  P. Sokol,et al.  Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides. , 2009, Microbiology.

[130]  J. Gunn,et al.  An Altered Immune Response, but Not Individual Cationic Antimicrobial Peptides, Is Associated with the Oral Attenuation of Ara4N-Deficient Salmonella enterica Serovar Typhimurium in Mice , 2012, PloS one.

[131]  C. Wiedermann,et al.  Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39 , 2007, TheScientificWorldJournal.

[132]  T. Cullen,et al.  Helicobacter pylori versus the Host: Remodeling of the Bacterial Outer Membrane Is Required for Survival in the Gastric Mucosa , 2011, PLoS pathogens.

[133]  J. Thomassin,et al.  OmpT Outer Membrane Proteases of Enterohemorrhagic and Enteropathogenic Escherichia coli Contribute Differently to the Degradation of Human LL-37 , 2011, Infection and Immunity.

[134]  K. Hahm,et al.  Investigating the effects of positive charge and hydrophobicity on the cell selectivity, mechanism of action and anti-inflammatory activity of a Trp-rich antimicrobial peptide indolicidin. , 2009, FEMS microbiology letters.

[135]  Michel Salzet,et al.  Antimicrobial peptides from animals: focus on invertebrates. , 2002, Trends in pharmacological sciences.

[136]  T. Ganz,et al.  Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. , 1989, The Journal of clinical investigation.

[137]  R. Suvanasuthi,et al.  Proteus mirabilis ZapA Metalloprotease Degrades a Broad Spectrum of Substrates, Including Antimicrobial Peptides , 2004, Infection and Immunity.

[138]  M. Yeaman,et al.  Peptide antimicrobials: cell wall as a bacterial target , 2013, Annals of the New York Academy of Sciences.

[139]  W. Shafer,et al.  Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases , 2004, Antimicrobial Agents and Chemotherapy.

[140]  P. Tempst,et al.  Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity. , 1994, Biochemical and biophysical research communications.

[141]  Manuela G. López,et al.  Peptide gomesin triggers cell death through L-type channel calcium influx, MAPK/ERK, PKC and PI3K signaling and generation of reactive oxygen species. , 2010, Chemico-biological interactions.

[142]  L. Björck,et al.  α2-Macroglobulin-Proteinase Complexes Protect Streptococcus pyogenes from Killing by the Antimicrobial Peptide LL-37* , 2004, Journal of Biological Chemistry.

[143]  K. Jolliffe,et al.  Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons , 2013, PloS one.

[144]  U. Zähringer,et al.  Isolation and characterisation of disodium (4-amino-4-deoxy-beta-L- arabinopyranosyl)-(1-->8)-(D-glycero-alpha-D-talo-oct-2-ulopyranosylona te)- (2-->4)-(methyl 3-deoxy-D-manno-oct-2-ulopyranosid)onate from the lipopolysaccharide of Burkholderia cepacia. , 1998, Carbohydrate research.

[145]  W. Shafer,et al.  Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[146]  S. Lewenza,et al.  Extracellular DNA Chelates Cations and Induces Antibiotic Resistance in Pseudomonas aeruginosa Biofilms , 2008, PLoS pathogens.

[147]  D. Elmore,et al.  Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II , 2008, FEBS letters.

[148]  A. Schmidtchen,et al.  Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial α‐defensin , 2001, Molecular microbiology.

[149]  B. Cookson,et al.  Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells , 2005, Infection and Immunity.

[150]  A. Mor,et al.  Antimicrobial peptide mimics for improved therapeutic properties. , 2009, Biochimica et biophysica acta.

[151]  R. Gennaro,et al.  Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. , 2000, Biopolymers.

[152]  J. Tomás,et al.  Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. , 2008, Microbiology.

[153]  V. Regueiro,et al.  Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides , 2004, Infection and Immunity.

[154]  H. Sahl,et al.  The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II , 1998, Antimicrobial Agents and Chemotherapy.

[155]  Y. Shai,et al.  Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .

[156]  C. Santa-Catarina,et al.  Antifungal Activity of PvD1 Defensin Involves Plasma Membrane Permeabilization, Inhibition of Medium Acidification, and Induction of ROS in Fungi Cells , 2011, Current Microbiology.

[157]  M. Schaller,et al.  Alternative approaches to antifungal therapies , 2012, Experimental dermatology.

[158]  E. Paredes-Gamero,et al.  Characterization of dual effects induced by antimicrobial peptides: regulated cell death or membrane disruption. , 2012, Biochimica et biophysica acta.

[159]  M. Valvano,et al.  Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia , 2011, Front. Cell. Inf. Microbio..

[160]  C. Bortner,et al.  Caspase Independent/Dependent Regulation of K+, Cell Shrinkage, and Mitochondrial Membrane Potential during Lymphocyte Apoptosis* , 1999, The Journal of Biological Chemistry.

[161]  Miriam Geörg,et al.  Endotoxin, Capsule, and Bacterial Attachment Contribute to Neisseria meningitidis Resistance to the Human Antimicrobial Peptide LL-37 , 2009, Journal of bacteriology.

[162]  K. Matsuzaki.  Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.